This special series on Epidemiology, Biomarkers and Modelling of Gastroesophageal Reflux Disease was co-edited by Dr. Peter W. Dettmar from Technostics Ltd & RD Biomed Ltd, Castle Hill Hospital, East Yorkshire, UK; and Dr. Jeffrey P. Pearson from Newcastle University Biosciences institute, The Medical School, Framlington Place, Newcastle upon Tyne, UK.
Editorial on Epidemiology, Biomarkers and Modelling of Gastroesophageal Reflux Disease
Epidemiology, biomarkers and modelling of gastroesophageal reflux disease
Review Article on Epidemiology, Biomarkers and Modelling of Gastroesophageal Reflux Disease
A narrative review of the prevalence of gastroesophageal reflux disease (GERD)
Pepsin properties, structure, and its accurate measurement: a narrative review
Original Article on Epidemiology, Biomarkers and Modelling of Gastroesophageal Reflux Disease
Pepsin as a biomarker for self-diagnosing reflux associated symptoms in UK and USA individuals
Pepsin as a biomarker of reflux in patients presenting at a UK ENT voice clinic
Review Article on Epidemiology, Biomarkers and Modelling of Gastroesophageal Reflux Disease
In vitro modelling of the mucosa of the oesophagus and upper digestive tract
Original Article on Epidemiology, Biomarkers and Modelling of Gastroesophageal Reflux Disease
The rheological properties of an alginate satiety formulation in a physiologically relevant human model gut system
Development of an infant stomach model: validation of products targeting reflux in neonates and infants
Review Article on Epidemiology, Biomarkers and Modelling of Gastroesophageal Reflux Disease
A narrative review of the potential role of microaspiration and a dysregulated aerodigestive microbiome in lung disease
Disclosure:
The series “Epidemiology, Biomarkers and Modelling of Gastroesophageal Reflux Disease” was commissioned by the editorial office, Annals of Esophagus without any sponsorship or funding. Peter W. Dettmar and Jeffrey P. Pearson served as the unpaid Guest Editors for the series.